President’s Corner April 2011.
- Published in:
- 2011
- By:
- Publication type:
- Proceeding
Works matching IS 03331024 AND DT 2011 AND VI 31 AND IP 5
Results: 20
1
2
CGRP in migraine.
- Published in:
- 2011
- By:
- Publication type:
- Letter
3
Further on menstrual paroxysmal hemicrania.
- Published in:
- 2011
- By:
- Publication type:
- Letter
4
Joint hypermobility syndrome: A common clinical disorder associated with migraine in women.
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 603, doi. 10.1177/0333102410392606
- By:
- Publication type:
- Article
5
Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: The results of a pilot study.
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 543, doi. 10.1177/0333102410392605
- By:
- Publication type:
- Article
6
Response to Tfelt-Hansen P: Is BOL-148 hallucinogenic?
- Published in:
- 2011
- By:
- Publication type:
- Letter
7
What we ask is what we get.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
8
Is BOL-148 hallucinogenic?
- Published in:
- 2011
- By:
- Publication type:
- Letter
9
Time trends in the prevalence of headache disorders. The Nord-Trøndelag Health Studies (HUNT 2 and HUNT 3).
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 585, doi. 10.1177/0333102410391488
- By:
- Publication type:
- Article
10
Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia.
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 614, doi. 10.1177/0333102410391487
- By:
- Publication type:
- Article
11
Clinical profile of cluster headaches in Japan: Low prevalence of chronic cluster headache, and uncoupling of sense and behaviour of restlessness.
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 628, doi. 10.1177/0333102410391486
- By:
- Publication type:
- Article
12
Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches.
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 550, doi. 10.1177/0333102410391485
- By:
- Publication type:
- Article
13
Prevalence of red ear syndrome in juvenile primary headaches.
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 597, doi. 10.1177/0333102410388437
- By:
- Publication type:
- Article
14
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study.
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 573, doi. 10.1177/0333102410388435
- By:
- Publication type:
- Article
15
Behavioural treatment programme contributes to normalization of contingent negative variation in children with migraine.
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 562, doi. 10.1177/0333102410388434
- By:
- Publication type:
- Article
16
Oxcarbazepine does not suppress cortical spreading depression.
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 537, doi. 10.1177/0333102410388433
- By:
- Publication type:
- Article
17
Medication adaptation headache.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
18
Levetiracetam in chronic daily headache: A double-blind, randomised placebo-controlled study.
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 530, doi. 10.1177/0333102410384886
- By:
- Publication type:
- Article
19
Prophylaxis of hemicrania continua: Three cases effectively treated with acemethacin.
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 625, doi. 10.1177/0333102410384884
- By:
- Publication type:
- Article
20
Chronic migraine: Classification and comparisons.
- Published in:
- Cephalalgia, 2011, v. 31, n. 5, p. 520, doi. 10.1177/0333102410383590
- By:
- Publication type:
- Article